Zilucoplan – July 2024

Zilucoplan; Solution for injection 16.6 mg in 0.416 mL (as tetrasodium) pre-filled syringe Solution for injection 23 mg in 0.574 mL (as tetrasodium) pre-filled syringe, Solution for injection 32.4 mg in 0.810 mL (as tetrasodium) pre-filled syringe; Zilbrysq®

  • Brand names:
    • Zilbrysq®
  • Pharmaceutical Company:
    • UCB AUSTRALIA PROPRIETARY LIMITED
  • Condition/Indication: Generalised myasthenia gravis (gMG)
  • Meeting Date: July 2024
  • https://resources.pbs.gov.au/pbs-files/industry/pbac/psd/2024/07/
  • https://resources.pbs.gov.au/pbs-files/industry/pbac/psd/2024/07/
Last updated
30 May 2025